Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11921
AS-IV attenuated Aβ1-42-induced mitochondrial dysfunction.
Published 2014“…Aβ1-42 significantly decreased both CcO activity and ATP which was reversed by pretreatment with AS-IV (25, 50 µM). …”
-
11922
-
11923
Effects of the transobturator tape procedure on overactive bladder symptoms and quality of life: a prospective study
Published 2019“…The objective and subjective cure rates were 96.2% and 56.7%, respectively. A total of 80.7% of the cases had a 15-point improvement in QoL scores. …”
-
11924
-
11925
Sensitivity-Controllable Liquid-Metal-Based Pressure Sensor for Wearable Applications
Published 2021“…Integration of E-bumps has increased the average sensitivity of the sensor to 0.0727 kPa<sup>–1</sup> (5.43 times higher), and A-bump integration has decreased the average sensitivity to 0.0004 Pa<sup>–1</sup> (91.65 times lower) in the range of 0–50 kPa, as compared to the pressure sensor without any microbumps. …”
-
11926
Sensitivity-Controllable Liquid-Metal-Based Pressure Sensor for Wearable Applications
Published 2021“…Integration of E-bumps has increased the average sensitivity of the sensor to 0.0727 kPa<sup>–1</sup> (5.43 times higher), and A-bump integration has decreased the average sensitivity to 0.0004 Pa<sup>–1</sup> (91.65 times lower) in the range of 0–50 kPa, as compared to the pressure sensor without any microbumps. …”
-
11927
Flow chart describing samples.
Published 2024“…If a child’s growth changed from severe stunting to normal growth, their risk of repeating a grade decreased by 5.0 [95% CI: 0.0; 9.0] per 100 persons-years. …”
-
11928
Uptake of the intervention (N = 49).
Published 2025“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”
-
11929
Baseline characteristics of sample by trial arm.
Published 2025“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”
-
11930
CweL trial design.
Published 2025“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”
-
11931
Participant Flow.
Published 2025“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”
-
11932
Economic cost composition by arm and outcomes.
Published 2025“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”
-
11933
-
11934
Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome
Published 2019“…<div><p>Quercetin shows protective effects against hepatopulmonary syndrome (HPS), as demonstrated in a rat model. However, whether these effects involve pulmonary vascular angiogenesis in HPS remains unclear. …”
-
11935
-
11936
-
11937
-
11938
-
11939
-
11940
Optimal screening time point for a single colonoscopy program in the US.
Published 2024“…Selected model parameters were increased and decreased by up to 50%, as indicated. The dashed line indicates the optimal schedule without parameter changes. …”